This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Drug Stocks With Upside Potential of 25%

2. Dr. Reddy's is an India-based pharmaceutical company operating in three business segments: global generics, pharmaceutical services and active ingredients.

During the September quarter, revenue improved 2%. Global generics sales rose 8% during the quarter, while pharmaceutical services and active ingredients saw a revenue decline of 14%. However, operating profit margin increased to 17% from 14% in the year-earlier period. Net profit improved 32% year on year during the same period.

The company announced the launch of 41 new generic products and filing of 21 new product registrations and 13 drug master files globally. Growth in North America and Europe, the company's largest markets, contributing more than 50% towards sales was slower than in markets like India and Russia. Revenue from North America and Europe declined 2% and 14% for the September quarter, respectively, compared to a 21% and 17% growth for India and Russia, respectively.
4 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
SHP $0.00 0.00%
NVS $94.21 1.00%
RDY $65.40 1.90%
TEVA $58.37 -2.80%
WX $43.34 -0.53%


Chart of I:DJI
DOW 16,776.43 +304.06 1.85%
S&P 500 1,987.05 +35.69 1.83%
NASDAQ 4,781.2640 +73.4890 1.56%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs